Clinical Trials Logo

Glucose Intolerance clinical trials

View clinical trials related to Glucose Intolerance.

Filter by:

NCT ID: NCT02689765 Completed - Type 2 Diabetes Clinical Trials

Effect of Anthocyanins on Metabolic Profiles in Subjects With Pre-diabetes

Start date: February 2016
Phase: Phase 4
Study type: Interventional

Metabolic problems represent one of the major health concerns which are attractive for being addressed by nutritional interventions, as these are directly connected to dietary habits.Anthocyans possess cardiovascular disease prevention, obesity control, and diabetes alleviation properties, but association between anthocyans and prediabetes need to be more firmly understood and established from robust clinical data. However, there is little human research that has reported on the efficacy of increased anthocyans bioactive consumption on insulin sensitivity in pre-diabetes.

NCT ID: NCT02683902 Recruiting - Obesity Clinical Trials

The Effect of Hypocaloric Diet Associated With tDCS on Weight Loss and Metabolic Profile

Start date: March 2016
Phase: N/A
Study type: Interventional

To compare four weeks of transcranial direct current stimulation (tDCS) versus placebo associated with a reduced caloric diet on weight loss, glycemic control and regulators of hunger and satiety in overweight or obese subjects with different degrees of glucose tolerance, submitted to hypocaloric diet.

NCT ID: NCT02676518 Recruiting - Clinical trials for Polycystic Ovary Syndrome

AMH, Glucose Intolerance and Metabolic Syndrome in PCOS

Start date: April 2015
Phase: N/A
Study type: Observational

Association between serum anti-Mullerian hormone (AMH) level and prevalence of glucose intolerance and metabolic syndrome in women with polycystic ovary syndrome (PCOS)

NCT ID: NCT02673762 Active, not recruiting - Insulin Resistance Clinical Trials

Salivary Transcriptome Biomarkers for Early Diabetes Detection

Start date: January 2016
Phase:
Study type: Observational

A PRoBE design study will be used to obtain saliva from patients before undergoing blood study evaluation for screening at risk patients for the presence of undiagnosed pre-diabetes of type II diabetes. Pre-specified saliva biomarkers will be evaluated along with multi-marker models for their discriminatory value for distinguishing patients with normal glucose metabolism from those with disease. Appropriate housekeeping genes will also be incorporated to allow for the measurement of relative gene expression.

NCT ID: NCT02664064 Completed - Obesity Clinical Trials

Evaluation of Prevent in Underserved Populations

PUP
Start date: January 2016
Phase: N/A
Study type: Interventional

The goal of this study is to evaluate an online Diabetes Prevention Program adapted for patients with prediabetes in safety net health care settings.

NCT ID: NCT02656212 Completed - Pre-diabetes Clinical Trials

Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin (Part 2)

Epicatechin
Start date: September 2015
Phase: Phase 1
Study type: Interventional

This will be a double-blind, randomized, placebo-controlled, single dose study of (+)- epicatechin with one 30mg dose/day for a total of 7 days

NCT ID: NCT02650830 Completed - Type 2 Diabetes Clinical Trials

Seum Bile Acid Profile in Type 2 Diabetes and Association Between Bile Cid Profile and Adipokine or Oxidative Stress

Start date: September 12, 2015
Phase:
Study type: Observational

"The goal of this work is to critically test the hypothesis that there exists a different profile of bile acids (BAs) in patient with type 2 diabetes mellitus (T2DM) compared with normal controls. Through confirmation of different profile of BAs in T2DM, investigator will suggest modulation of specific bile acids as a new possible treatment target in patients with T2DM. Investigator also expect the specific BAs signature will be used to screen T2DM before hyperglycemia. In addition, investigator will evaluate the association between each BA species and serum total glucagon like peptide-1 (GLP-1) or fibroblast growth factor-19 (FGF-19) concentrations to determine if the specific BAs profile is related with total GLP-1 or FGF-19 concentration in serum. Investigatr also evaluates the correlation between each BA species and metabolic profiles and oxidative stress marker to find possible roles of each BA component in glucose metabolism.

NCT ID: NCT02635646 Completed - Prediabetes Clinical Trials

Interdisciplinary and Family Intervention to Prevent Type 2 Diabetes

CARE-in-DEEP
Start date: October 2015
Phase: N/A
Study type: Interventional

The purpose of the study is to evaluate the effect of a family and interdisciplinary approach on individual and family insulin resistance and insulin secretion in patients with prediabetes.

NCT ID: NCT02634593 Completed - Obesity Clinical Trials

The Snack Study: The Feasibility of Changing Night-time Food Choices to Improve Glucose Tolerance in Pregnancy

Start date: June 2016
Phase: N/A
Study type: Interventional

Obesity during pregnancy increases the risk for high glucose and diabetes in the mother, and for obesity and comorbid metabolic disease in the offspring. Results of previous intervention studies designed to improve the metabolic health of obese mothers, and thereby reduce the risk to their offspring, have been modest at best. Furthermore, few studies have proved to be efficacious among low income African American women who have high risk for the transmission of obesity to future generations. The purpose of this study is to examine the feasibility of changing the types of foods and drinks that are consumed at night during late pregnancy in order to improve maternal glucose tolerance and reduce the risk for future obesity in the child.

NCT ID: NCT02621060 Completed - Clinical trials for Impaired Glucose Tolerance

Effect of Chlorogenic Acid on Patients With Impaired Glucose Tolerance

Start date: September 2015
Phase: Phase 2
Study type: Interventional

Chlorogenic acid has demonstrated promising effects in the treatment of glycemic control, obesity, dyslipidemia, insulin secretion, among others. The above mentioned findings show that Chlorogenic acid has an excellent potential for the control of glucose as well as insulin secretion and insulin sensitivity.